medigraphic.com
ISSN 2078-7162 (Print)

2013, Number 1

<< Back Next >>

Rev Cub de Med Fis y Rehab 2013; 5 (1)

Utility of the magnetoterapia and the ion cleanse in patient with illness renal secondary chronicle

Martínez MY, Pérez RZM, Mora GSR, Rodríguez AN, González RO

Language: Spanish
References: 33
Page: 17-31
PDF size: 158.56 Kb.


ABSTRACT

Objective: To determine the utility of the ion cleanse and the magnetoterapia in patient with illness renal chronicle in phases 1 at 4 o'clock.
Method: He/she was carried out an experimental study, in 60 patients with Illness Renal Chronicle, with the objective of evaluating the answer to the treatment 3 groups of 20 patients were determined each one, Group I (control) they received pharmacological treatment, dietary hygienic measures and control of the toxic habits. Group II treatment similar to the group I, more ion cleanse way 1 30 minutes and group III treatment similar to the group I more bed magnetic 20 Hz 100 % in area of renal projection, for 30 session-days. The effectiveness of the treatment was evaluated before and later (symptoms, creatinina results, uric acid, urea, cholesterol, triglycerides, proteinuria and filtered glomerular). In the statistical prosecution the percent, the test chi was used 2 or MacNemar, test of Student and K. Wallis.
Results: Group (control) after the treatment in most of the variables changes didn't take place or they worsened (Filtered Glomerular diminished in 1, 7 ml/min / 1,73 m2). Group II (Ion cleanse) after the treatment but of 40 % of the patients they were with normal values (uric acid 80 %, triglycerides 90 %, cholesterol 65 %, urea 40 % and 75 % without proteinuria) and the F.G. it increased in 10,9 ml/min / 1,73 m2. The group III (magnetic bed) after the treatment they reached figures of normality but of 65 % of the patients (uric acid 70 %, triglycerides 90 %, cholesterol 75 %, urea 65 % and 70 % without proteinuria) and the F.G., it increased in 21 ml/min / 1,73 m2, being statistically significant in both groups.
Conclusions: So much with the ion cleanse as with the magnetic bed, most of the patients improve or they normalize the clinical parameters and of laboratory independently of the phase in that you/they are, that which retards or it stops the progress of the illness.


REFERENCES

  1. Treviño Becerra Alejandro. Insuficiencia Renal Crónica: enfermedad emergente, catastrófica y por ella prioritaria. Cir. Ciruj 2004.72:3-4.

  2. Álvarez Sintes R. Prevención en enfermedades renales. Medicina General Integral II Cáp. 54 Pág. 759; 2001.

  3. Arce Bustabad Sergio, et al. Transplante Renal y Enfermedad Renal Crónica. Sistema de leyes integradoras. La Habana. Editorial Ciencias Medicas.cap 1 y 2:23- 49. 2009

  4. National Kidney Foundation: K l DOQI. Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, Classification and stratification». Am. J. kidney Dis.2002; 39: s-1-s-266.

  5. Mezzano SA, Claudio Aros E et al. Enfermedad Renal Crónica: Clasificación, Mecanismos de Progresión. Revista Medica de Chile; 2007; 133; 338: 348.

  6. Betancourt Reyes A., Pérez Rodríguez Z.M., Rodríguez Hernández E.I., Rodríguez Apolinario N. Magnetoterapia en pacientes con enfermedad renal crónica secundaria Fase 1 y 2 Rev Cubana Med Mil [Revista en Internet] .2011 Dic 26; 40(3-4). Disponible en: http//bvs.sld.cu/revistas/mil/vol40_3-4_11/mil 09311.htm.

  7. Brenner BM, Chestow GM. Adaptation to nephron loss, kidney Int.25:783- 810.2008.

  8. MedlinePlus (agosto de 2007). Dieta para personas con enfermedad renal crónica Enciclopedia médica en español. Consultado el 25 de junio de 2009.

  9. Alcázar R, De Francisco ALM., et al. Acción estratégica frente a la enfermedad renal. Nefrología. 2008.

  10. Arredondo A, Rangel R, De casa R., et al. Costos efectividad de intervenciones para insuficiencia renal terminal crónica. Revista de Saudé Pública. 2007 .Scielo Public Heath

  11. Goodman R, Blank M. Insights into electromagnetic interaction mechanisms. J Cell Physiol.; 192(1):16-22. 2002 Jul

  12. Rosen AD. Mechanism of action of moderate-intensity static magnetic fields on biological systems. Cell Biochem Biophys 2003; 39:163173.

  13. Baureus Koch CL, Sommarin M, Persson BR, Salford LG, Eberhardt JL. Interaction between weak low frequency magnetic fields and cell membranes. Bioelectromagnetics. 2003 Sep; 24(6):395-402.

  14. Ohata R, Tomita N, Ikada Y. Effect of a static magnetic field on ion transport in a cellulose membrane. J Colloid Interface Sci. 2004; 270:413416.

  15. Martín Cordero J. E., et al. Agentes Físicos Terapéuticos, Editorial Ciencias Médicas. La Habana Cuba 2008. Revista Cubana de Medicina Física y Rehabilitación 2013;5(1):17-31 30

  16. BHL Ion Cleanse Toxin Draining Device Cref-international service. Disponible en: www.drenatoxinas.com, http://eliumfoundation.org.

  17. Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G. El tratamiento en la enfermedad renal crónica, Kidney Int 2007; 72: 247-259.

  18. Angel L. M., et al. Estudio epidemiológico de pacientes ancianos con insuficiencia renal crónica en hemodiálisis. Nefrología 28(1)2008.

  19. Cano, A., et al. Prevalencia de IRC en atención primaria. Atención primaria 29(2) 2002.

  20. Almirall J., et al. Prevalencia de la insuficiencia renal en la población mayor de 4 años y episodios cardiovasculares asociados. nefrología 25(6) 2005.

  21. Fransisco Buitrago JJ., et al. Comparación y concordancia de las ecuaciones de estimación de FG de Cockcrof-gault y MDRD en diagnostico de enfermedad renal crónica oculta. Nefrología.2008 28(3) 301-310.

  22. Angel de Fransisco L. M., et al. Prevalencia de Insuficiencia renal en centros de atención primaria en España. Nefrologia 2007.27 (3).

  23. Roca GR, Smith SV, Paz PE, Losada GJ, Serret RB, Llamos SN, et al. Insuficiencia renal crónica. Temas de Medicina Interna. 4ta Ed. Ciudad Habana: Editorial Ciencias médicas; p. 128-133. 2002.

  24. Otero A. Abelleira A, Gayoso P: Enfermedad renal crónica oculta y factores de riesgos vascular asociado. Sociedad Española de Nefrología: 2007. Disponible en: http://Colombia Médica.Univalle.edu.co/vol.33 No1/renal.htm

  25. Wolf M, Shah A, Gutiérrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang; Nefrología e Hipertensión; Kidney int. 2007; 72: 1004-13.

  26. Tolkoff-Rubin N. Treatment of irreversible renal failure. In: Goldman L, Ausiello D, eds. Cecil Medicine. 23rd ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 133.

  27. Beers MH. El Manual Merck Trastornos Genito Urinario. Insuficiencia Renal Crónica. T7. Secc 17 Pp. 2185-2201. ELSEVIER. 2007. Barcelona.

  28. Madroñero de la Cal A. Utilización terapéutica de los campos magnéticos. I: Fundamentos del biomagnetismo. Patología del Aparato Locomotor; 2004 2 (1): 22-37.

  29. Levin M. Bioelectromagnetics in morphogenesis. Bioelectromagnetics. 2003 Jul; 24 (5):295-315.

  30. Valencia, M.E;E.J.Weil, R.G. Nelson and J. Esparza. Impact of lifestyle on prevalence of kidney disease in Pima Indians in Mexico and the United States. Kidney Int.2005; 68(97):141-144.

  31. Okano H, Masuda H, Ohkubo C. Decreased plasma levels of nitric oxide metabolites, angiotensin II, and aldosterone in spontaneously hypertensive rats exposed to 5 mT static magnetic fields. Bioelectromagnetics. Apr 2005 26(3):161-72. Revista Cubana de Medicina Física y Rehabilitación 2013;5(1):17-31 31

  32. Alberto D, Busso L, Crotti G, Gandini M, Garfagnini R, Giudici P, Gnesi I, Manta F, Piragino G. Effects of static and low-frequency alternating magnetic fields on the ionic electrolytic currents of glutamic acid aqueous solutions. Electromagn Biol Med. 2008; 27(1):25-39.

  33. Okano H, Ohkubo C. Anti-pressor effects of whole body exposure to static magnetic field on pharmacologically induced hypertension in conscious rabbits. Bioelectromagnetics. 2003 Feb; 24(2):139-47.




2020     |     www.medigraphic.com